BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23999102)

  • 1. Seeded strain-like transmission of β-amyloid morphotypes in APP transgenic mice.
    Heilbronner G; Eisele YS; Langer F; Kaeser SA; Novotny R; Nagarathinam A; Aslund A; Hammarström P; Nilsson KP; Jucker M
    EMBO Rep; 2013 Nov; 14(11):1017-22. PubMed ID: 23999102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent Age-Dependent Conformational Rearrangement within Aβ Amyloid Deposits in APP23, APPPS1, and
    Parvin F; Haglund S; Wegenast-Braun B; Jucker M; Saito T; Saido TC; Nilsson KPR; Nilsson P; Nyström S; Hammarström P
    ACS Chem Neurosci; 2024 May; 15(10):2058-2069. PubMed ID: 38652895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous murine Aβ increases amyloid deposition in APP23 but not in APPPS1 transgenic mice.
    Mahler J; Morales-Corraliza J; Stolz J; Skodras A; Radde R; Duma CC; Eisele YS; Mazzella MJ; Wong H; Klunk WE; Nilsson KPR; Staufenbiel M; Mathews PM; Jucker M; Wegenast-Braun BM
    Neurobiol Aging; 2015 Jul; 36(7):2241-2247. PubMed ID: 25911278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calpastatin modulates APP processing in the brains of β-amyloid depositing but not wild-type mice.
    Morales-Corraliza J; Berger JD; Mazzella MJ; Veeranna ; Neubert TA; Ghiso J; Rao MV; Staufenbiel M; Nixon RA; Mathews PM
    Neurobiol Aging; 2012 Jun; 33(6):1125.e9-18. PubMed ID: 22206846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
    Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
    J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein.
    Maia LF; Kaeser SA; Reichwald J; Hruscha M; Martus P; Staufenbiel M; Jucker M
    Sci Transl Med; 2013 Jul; 5(194):194re2. PubMed ID: 23863834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice.
    Bolmont T; Clavaguera F; Meyer-Luehmann M; Herzig MC; Radde R; Staufenbiel M; Lewis J; Hutton M; Tolnay M; Jucker M
    Am J Pathol; 2007 Dec; 171(6):2012-20. PubMed ID: 18055549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of tissue transglutaminase reduces amyloid-beta pathology in APP23 mice.
    Wilhelmus MMM; Chouchane O; Loos M; Jongenelen CAM; Brevé JJP; Jonker A; Bol JGJM; Smit AB; Drukarch B
    Neuropathol Appl Neurobiol; 2022 Jun; 48(4):e12796. PubMed ID: 35141929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ seeding potency peaks in the early stages of cerebral β-amyloidosis.
    Ye L; Rasmussen J; Kaeser SA; Marzesco AM; Obermüller U; Mahler J; Schelle J; Odenthal J; Krüger C; Fritschi SK; Walker LC; Staufenbiel M; Baumann F; Jucker M
    EMBO Rep; 2017 Sep; 18(9):1536-1544. PubMed ID: 28701326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
    Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
    Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
    Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F
    Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenesis and alterations of neural stem cells in mouse models of cerebral amyloidosis.
    Ermini FV; Grathwohl S; Radde R; Yamaguchi M; Staufenbiel M; Palmer TD; Jucker M
    Am J Pathol; 2008 Jun; 172(6):1520-8. PubMed ID: 18467698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of Synthetic Aβ to In Vivo Active Seeds and Amyloid Plaque Formation in a Hippocampal Slice Culture Model.
    Novotny R; Langer F; Mahler J; Skodras A; Vlachos A; Wegenast-Braun BM; Kaeser SA; Neher JJ; Eisele YS; Pietrowski MJ; Nilsson KP; Deller T; Staufenbiel M; Heimrich B; Jucker M
    J Neurosci; 2016 May; 36(18):5084-93. PubMed ID: 27147660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice.
    Nunes AF; Amaral JD; Lo AC; Fonseca MB; Viana RJ; Callaerts-Vegh Z; D'Hooge R; Rodrigues CM
    Mol Neurobiol; 2012 Jun; 45(3):440-54. PubMed ID: 22438081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.
    Kuo YM; Beach TG; Sue LI; Scott S; Layne KJ; Kokjohn TA; Kalback WM; Luehrs DC; Vishnivetskaya TA; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller RO; Roher AE
    Mol Med; 2001 Sep; 7(9):609-18. PubMed ID: 11778650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice.
    Bayer TA; Schäfer S; Simons A; Kemmling A; Kamer T; Tepest R; Eckert A; Schüssel K; Eikenberg O; Sturchler-Pierrat C; Abramowski D; Staufenbiel M; Multhaup G
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14187-92. PubMed ID: 14617773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA; Davies DC; Kidd M; Duff K; Rolph SC; Jennings KH; Howlett DR
    Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.